Top news of the week: 21.10.2022.
Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus
Eli Lilly has agreed to acquire Akouos for up to $610 million, in a deal intended to expand the buyer’s presence in gene therapy with a focus on treating inner ear disorders.
10 Reasons to Keep an Eye on Chicago Biotech in 2023
Between top-notch academic institutions, solid venture capital funding, expanding lab space and governmental support, Chicago is emerging as a true hotbed for biotech growth.
Israel: An Untapped Biotech Investment Opportunity
With military precision and academic ingenuity, Israel is building a thriving biotech ecosystem. Venture capitalists would do well to pay attention.
Why Hiring Managers Must Act Differently to Stay Competitive in Today’s Job-Seeker’s Market
In the wake of a global pandemic and economic downturn, the hiring market has turned on its head. BioSpace spoke with PharmaLogics Recruiting to learn how employers can stay competitive.
Oculis to go public via SPAC deal with EBAC
Oculis to go public via SPAC deal with EBAC
AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
BRISBANE, AUS, Oct 18, 2022 - (ACN Newswire) - AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. ...
Milestone Pharma claims PhIII redemption for its once-failed heart drug, putting it on a path to the FDA
More than two years after Milestone Pharmaceuticals’ stock got hammered after their lead heart drug flopped in a crucial Phase III study, the biotech is looking for some redemption now that ...
Is Technology Diversifying Biomedical R&D Outputs?
With advances in technology and their adoption occurring faster than ever before in all aspects of our lives, it is perhaps surprising that the field of biotechnology is only fairly ...